Skip to content
How It Works
Explore
Ask a Question Resources Pricing
Who It's For
Patients
Decode results, prep for appointments, weigh options.
Caregivers & advocates
Carry the research load for someone you love.
Providers & clinicians
Resources for patients in your practice.
Log In Sign Up
PubMed This is a summary of 26 peer-reviewed journal articles Updated
Clinical Immunology

Living with Resilience: Monitoring and Long-Term Care

At a Glance

Long-term care for CD27 deficiency relies on regular EBV blood testing, antibody-level checks, infection and vaccine precautions, and individualized follow-up. After stem cell transplant, monitoring continues for immune recovery, donor-cell levels, and late effects.

Living with CD27 deficiency requires a shift in perspective. It is about moving from a state of constant emergency to a state of informed vigilance. While the diagnosis brings significant changes to your daily routine, many families find that having a structured monitoring plan helps transform “fear of the unknown” into a manageable medical strategy [1][2].

Routine Monitoring: Planned Surveillance

Because the primary risk in CD27 deficiency is the body’s impaired ability to control the Epstein-Barr Virus (EBV), your medical team will implement a rigorous surveillance schedule. This is often called planned surveillance, and it focuses on two main pillars:

  1. Quantitative EBV PCR: This blood test measures the exact number of copies of EBV DNA in your blood [3]. Treatment decisions are made by interpreting serial results in clinical context—depending on the assay, trend, symptoms, and organ findings—not a single universal number [4][5].
  2. IgG Trough Levels: If you are on Immunoglobulin Replacement Therapy (IRT), your team will periodically check your trough level—the lowest point your antibody levels reach just before your next dose [6]. Keeping this level optimal for you to prevent bacterial infections is a key goal of daily management [7][8].

Routine physical exams are also vital. Your doctor will feel for any new firm lumps (lymphadenopathy) or a swollen abdomen, which could indicate that the liver or spleen is enlarging [8][5].

Daily Life and Practical Safety

Protecting your health does not mean living in total isolation, but it does require specific precautions:

  • Vaccine Safety: A patient with a combined immunodeficiency should not receive a live vaccine unless the immunologist explicitly approves it. Because these vaccines contain a weakened but live version of a virus (like the oral polio vaccine or the BCG vaccine for tuberculosis), they are generally contraindicated [9][10][11]. However, non-live vaccines are often recommended depending on immune phenotype and transplant status. Household vaccination advice should come from the care team [12].
  • Infection Prevention: Simple, consistent habits are your best defense. This includes thorough handwashing, staying away from people who are visibly sick, and ensuring good hygiene [13][14]. EBV is ubiquitous, so exposure cannot be completely prevented.
  • School and Work: Many children and adults with CD27 deficiency can attend school or work, but it may require an individualized plan (such as a 504 plan in the U.S.) to manage absences for infusions and to establish local outbreak notification protocols [15][16].

Managing the Emotional Burden

It is completely normal to feel “scan anxiety” or a sense of dread while waiting for EBV test results. Research shows that families living with rare immune disorders often experience higher levels of anxiety and depression than the general population [17][18].

Connecting with other families through rare disease networks or working with a therapist who understands chronic illness can be just as important as your medical treatments [14]. Transitioning to home-based subcutaneous infusions (SCIG) can also improve quality of life by giving you more control over your schedule and reducing the time spent in hospitals [19].

Survivorship: Life After a Transplant

If you undergo a Hematopoietic Stem Cell Transplant (HSCT), survivorship is a long-term process that continues for years after the procedure [20].

  • Chimerism Monitoring: After the transplant, doctors will track your chimerism—the percentage of your blood cells that come from the donor versus your own original cells [21]. Lineage-specific chimerism, immune-cell recovery, and clinical status all matter; some mixed chimerism can still be clinically adequate [22].
  • Immune Reconstitution: The new immune system takes time to mature. During this time, IRT and antivirals may be needed until objective recovery is demonstrated, according to the center’s protocol and the patient’s individual B-cell recovery and infection risks [23][24].
  • Late Effects: Even after a successful transplant, survivors need lifelong follow-up to monitor for late complications, such as effects on fertility, thyroid function, or a small increased risk of secondary cancers caused by the transplant’s conditioning chemotherapy [25][26][20].

The journey with CD27 deficiency is long, but with a dedicated care team and a proactive monitoring plan, many patients can move forward with confidence [16][2].

Common questions in this guide

Why do I need regular EBV testing with CD27 deficiency?
A quantitative EBV PCR is a blood test that measures the amount of EBV DNA in the blood. Doctors compare results over time and interpret them with symptoms and organ findings rather than relying on one universal cutoff.
What is an IgG trough level, and why is it checked?
An IgG trough is the lowest antibody level measured just before the next immunoglobulin dose. Your care team uses it, along with your infection history, to help adjust treatment and reduce bacterial infections.
Which vaccines should someone with CD27 deficiency avoid?
Live vaccines, such as oral polio and the BCG tuberculosis vaccine, are generally avoided in combined immunodeficiency unless an immunologist specifically approves them. Non-live vaccines may be recommended, but the plan depends on the person's immune status and whether they have had a transplant.
Can a child or adult with CD27 deficiency attend school or work?
Many people can attend school or work with an individualized plan. The plan may cover absences for infusions, infection precautions, and a process for receiving notice about local outbreaks.
What follow-up is needed after a stem cell transplant?
Follow-up checks how much of the blood system comes from the donor, how the new immune system is recovering, and whether infections or other problems occur. Immunoglobulin treatment or antiviral medicine may continue until objective immune recovery, and lifelong visits may monitor fertility, thyroid function, and a small increased risk of secondary cancers.
How can families manage anxiety and daily life with CD27 deficiency?
Anxiety while waiting for surveillance results is understandable, and support from rare-disease networks or a therapist familiar with chronic illness can help. Home-based subcutaneous immunoglobulin infusions may also give some people more control over their schedule and reduce hospital time.

Get notified when new evidence is published on Combined immunodeficiency due to CD27 deficiency.

We monitor PubMed for new peer-reviewed studies on this topic and email a short summary when something meaningful changes.

References

References (26)
  1. 1

    "I am sick, but that's not all that I am": patient perspectives on psychological adaptation over time to inborn errors of immunity.

    Beers BJ, Davidson-Swinton HR, Lewis KL, et al.

    Journal of community genetics 2025; (16(2)):117-130 doi:10.1007/s12687-024-00758-z.

    PMID: 39760816
  2. 2

    Perceived control is significantly associated with psychological adaptation in individuals with known or suspected inborn errors of immunity.

    Setzer M, Yan J, Erby L, Similuk M

    Journal of community genetics 2023; (14(6)):639-647 doi:10.1007/s12687-023-00670-y.

    PMID: 37709977
  3. 3

    Quantitative PCR for Plasma Epstein-Barr Virus Loads in Cancer Diagnostics.

    Loghavi S

    Methods in molecular biology (Clifton, N.J.) 2016; (1392()):51-61 doi:10.1007/978-1-4939-3360-0_6.

    PMID: 26843046
  4. 4

    Impact of Epstein Barr virus-related complications after high-risk allo-SCT in the era of pre-emptive rituximab.

    García-Cadenas I, Castillo N, Martino R, et al.

    Bone marrow transplantation 2015; (50(4)):579-84 doi:10.1038/bmt.2014.298.

    PMID: 25581404
  5. 5

    Novel mutation in the CD27 gene in a patient presenting with hypogammaglobulinemia, bronchiectasis and EBV-driven lymphoproliferative disease.

    Kishore R, Gupta A, Gupta AK, Kabra SK

    BMJ case reports 2020; (13(2)) doi:10.1136/bcr-2019-233482.

    PMID: 32041749
  6. 6

    Primary immunodeficiency.

    McCusker C, Upton J, Warrington R

    Allergy, asthma, and clinical immunology : official journal of the Canadian Society of Allergy and Clinical Immunology 2018; (14(Suppl 2)):61 doi:10.1186/s13223-018-0290-5.

    PMID: 30275850
  7. 7

    Mechanisms of action of Ig preparations: immunomodulatory and anti-inflammatory effects.

    Matucci A, Maggi E, Vultaggio A

    Frontiers in immunology 2014; (5()):690 doi:10.3389/fimmu.2014.00690.

    PMID: 25628625
  8. 8

    Novel mutations in TNFRSF7/CD27: Clinical, immunologic, and genetic characterization of human CD27 deficiency.

    Alkhairy OK, Perez-Becker R, Driessen GJ, et al.

    The Journal of allergy and clinical immunology 2015; (136(3)):703-712.e10.

    PMID: 25843314
  9. 9

    Guidelines for Screening, Early Diagnosis and Management of Severe Combined Immunodeficiency (SCID) in India.

    Madkaikar M, Aluri J, Gupta S

    Indian journal of pediatrics 2016; (83(5)):455-62 doi:10.1007/s12098-016-2059-5.

    PMID: 26920398
  10. 10

    Excretion and clearance of Sabin-like type 3 poliovirus in a child diagnosed with severe combined immunodeficiency.

    Yao N, Liu Y, Zhang ZY, et al.

    Human vaccines & immunotherapeutics 2025; (21(1)):2484882 doi:10.1080/21645515.2025.2484882.

    PMID: 40170570
  11. 11

    New insights into physiopathology of immunodeficiency-associated vaccine-derived poliovirus infection; systematic review of over 5 decades of data.

    Shaghaghi M, Soleyman-Jahi S, Abolhassani H, et al.

    Vaccine 2018; (36(13)):1711-1719 doi:10.1016/j.vaccine.2018.02.059.

    PMID: 29478755
  12. 12

    Spectrum of Inborn errors of immunity in a cohort of 90 patients presenting with complications to BCG vaccination in India.

    Yadav RM, Dalvi A, Gupta M, et al.

    Scandinavian journal of immunology 2021; (93(5)):e13010 doi:10.1111/sji.13010.

    PMID: 33325540
  13. 13

    Vaccination post-allogeneic hematopoietic stem cell transplantation: what is feasible?

    Conrad A, Alcazer V, Valour F, et al.

    Expert review of vaccines 2018; (17(4)):299-309 doi:10.1080/14760584.2018.1449649.

    PMID: 29561216
  14. 14

    Shared Decision-Making and Health-Related Quality of Life in the Diagnosis and Management of Patients With Inborn Errors of Immunity.

    Lawrence MG, Kim VHD, Orange JS, Scherzer R

    The journal of allergy and clinical immunology. In practice 2026; doi:10.1016/j.jaip.2026.07.010.

    PMID: 42447994
  15. 15

    Inborn errors of immunity at school: How can we do better?

    Lopez-Seguer L, Rodriguez-Tello S, Gonzalez-Amores M, et al.

    Journal of human immunity 2026; (2(3)):e20250120 doi:10.70962/jhi.20250120.

    PMID: 42170002
  16. 16

    Beyond immune recovery: Quality of life and psychosocial challenges in children with inborn errors of immunity after transplantation.

    Aydemir S, Nurhan E, Turan I, et al.

    Irish journal of medical science 2026; doi:10.1007/s11845-026-04480-2.

    PMID: 42287508
  17. 17

    Psychological Symptoms in Patients with Inborn Errors of Immunity and Their Family Members: A Cross-Sectional Study.

    Alpagat G, Nas N

    Medicina (Kaunas, Lithuania) 2026; (62(8)) doi:10.3390/medicina62081616.

    PMID: 42654513
  18. 18

    Frequency of depression and anxiety in patients with inborn errors of immunity: a cross-sectional study.

    Wolff LJ, Witte T, Kahl KG, et al.

    BMC psychiatry 2026; (26(1)).

    PMID: 42745244
  19. 19

    Multidimensional Assessment of Patient-Reported-Outcomes in a Multicenter Cohort of Inborn Errors of Immunity.

    Yorgun Altunbas M, Sefer AP, Bilgic-Eltan S, et al.

    Journal of clinical immunology 2026; (46(1)):18 doi:10.1007/s10875-025-01972-1.

    PMID: 41493669
  20. 20

    Assessment of Survivorship in Allogeneic Hematopoietic Stem Cell Transplantation.

    McErlean G

    Methods in molecular biology (Clifton, N.J.) 2025; (2907()):91-125 doi:10.1007/978-1-0716-4430-0_5.

    PMID: 40100595
  21. 21

    Retrospective, Landmark Analysis of Long-term Adult Morbidity Following Allogeneic HSCT for Inborn Errors of Immunity in Infancy and Childhood.

    Day JW, Elfeky R, Nicholson B, et al.

    Journal of clinical immunology 2022; (42(6)):1230-1243 doi:10.1007/s10875-022-01278-6.

    PMID: 35579633
  22. 22

    Immune reconstitution and survival, following hematopoietic stem cell transplantation in Omani patients with inborn errors of immunity.

    Al-Tamemi S, Al-Rawas A, Al-Khabori M, et al.

    Clinical immunology (Orlando, Fla.) 2024; (264()):110263 doi:10.1016/j.clim.2024.110263.

    PMID: 38795901
  23. 23

    Outcomes after Haploidentical Stem Cell Transplantation with Post-Transplantation Cyclophosphamide in Patients with Primary Immunodeficiency Diseases.

    Fernandes JF, Nichele S, Arcuri LJ, et al.

    Biology of blood and marrow transplantation : journal of the American Society for Blood and Marrow Transplantation 2020; (26(10)):1923-1929 doi:10.1016/j.bbmt.2020.07.003.

    PMID: 32653621
  24. 24

    An overview of infectious complications after allogeneic hematopoietic stem cell transplantation.

    Sahin U, Toprak SK, Atilla PA, et al.

    Journal of infection and chemotherapy : official journal of the Japan Society of Chemotherapy 2016; (22(8)):505-14.

    PMID: 27344206
  25. 25

    A review of late complications of allogeneic hematopoietic stem cell transplantations.

    Atilla E, Atilla PA, Toprak SK, Demirer T

    Clinical transplantation 2017; (31(10)) doi:10.1111/ctr.13062.

    PMID: 28753218
  26. 26

    A Systematic Review and Meta-Analysis of Risk Factors for Secondary Oral Squamous Cell Carcinoma After Allogeneic Hematopoietic Stem Cell Transplantation.

    Huang J, Liu J, Jiang Q, Tao R

    Head & neck 2026; (48(8)):2238-2249 doi:10.1002/hed.70346.

    PMID: 42286936

This page about long-term care for CD27 deficiency is for informational purposes only and does not constitute medical advice. Your immunologist and transplant team should tailor testing, vaccines, treatments, and activity decisions to your situation.

Guide contents Combined immunodeficiency due to CD27 deficiency
Research & Literature
04 Standard of Care and Treatment Strategies